Abstract
Phytochemical investigation of the methanolic extract of the aerial parts of Artemisia absinthium Linn. (Asteraceae) yielded four new phytoconstituents characterized as stigmast-5,22-dien-3β-ol-21-oic acid-3β-glucopyranosyl-2'- octadec-9''-enoate (1); lanost-24-en-3β-ol-11-one-28-oic acid-21,23 α-olide-3β-D-glucopyranosyl-2'-dihydrocaffeoate-6'- decanoate (2); tricosan-14-on-1,4-olide-5-eicos-9'-enoate (3) and 3,11-dimethyldodecan-1,7-dioic acid-1-β-D-glucopyranosyl-6'- octadec-9''-enoate (4). The structures of these phytoconstituents have been elucidated on the basis of spectral data analysis and chemical reactions.
Keywords: Artemisia absinthium, asteraceae, glycoside ester, lanostenolide, stigmastane.
The Natural Products Journal
Title:New Glycoside Esters from the Aerial Parts of Artemisia absinthium Linn.
Volume: 3 Issue: 4
Author(s): Javed Ahamad, Kamran J. Naquvi, Mohammed Ali and Showkat R. Mir
Affiliation:
Keywords: Artemisia absinthium, asteraceae, glycoside ester, lanostenolide, stigmastane.
Abstract: Phytochemical investigation of the methanolic extract of the aerial parts of Artemisia absinthium Linn. (Asteraceae) yielded four new phytoconstituents characterized as stigmast-5,22-dien-3β-ol-21-oic acid-3β-glucopyranosyl-2'- octadec-9''-enoate (1); lanost-24-en-3β-ol-11-one-28-oic acid-21,23 α-olide-3β-D-glucopyranosyl-2'-dihydrocaffeoate-6'- decanoate (2); tricosan-14-on-1,4-olide-5-eicos-9'-enoate (3) and 3,11-dimethyldodecan-1,7-dioic acid-1-β-D-glucopyranosyl-6'- octadec-9''-enoate (4). The structures of these phytoconstituents have been elucidated on the basis of spectral data analysis and chemical reactions.
Export Options
About this article
Cite this article as:
Ahamad Javed, Naquvi J. Kamran, Ali Mohammed and Mir R. Showkat, New Glycoside Esters from the Aerial Parts of Artemisia absinthium Linn., The Natural Products Journal 2013; 3 (4) . https://dx.doi.org/10.2174/221031550304140328113518
DOI https://dx.doi.org/10.2174/221031550304140328113518 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aspartate and Glutamate Mimetic Structures in Biologically Active Compounds
Current Medicinal Chemistry Cardiac ATP-Sensitive Potassium Channels: A Potential Target for an Anti-Ischaemic Pharmacological Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry Teratogenic Activity of HDAC Inhibitors
Current Pharmaceutical Design Mesenchymal Stem Cells Targeting of Systemic Disorders in Age-related Macular Degeneration
Current Tissue Engineering (Discontinued) Curcumin: Structure-Activity Relationship Towards its Role as a Versatile Multi-Targeted Therapeutics
Mini-Reviews in Organic Chemistry Comparison of Valvulopathy Risk with Lorcaserin and Phenterminetopiramate for Weight Loss
Current Drug Therapy Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research Citrus Peel Extract Attenuates Acute Cyanide Poisoning-Induced Seizures and Oxidative Stress in Rats
CNS & Neurological Disorders - Drug Targets Therapeutic Strategies for Treatment of Inflammation-related Depression
Current Neuropharmacology Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Current Neuropharmacology On Various Metrics Used for Validation of Predictive QSAR Models with Applications in Virtual Screening and Focused Library Design
Combinatorial Chemistry & High Throughput Screening Anticonvulsant Activity of A Novel Series of 2,5-Disubstituted 1,3,4-Oxadiazoles: Semicarbazones Based Pharmacophoric Model Studies
Letters in Drug Design & Discovery Meet the Editorial Board Member
CNS & Neurological Disorders - Drug Targets Design, Synthesis and Evaluation of the Antidepressant and Anticonvulsant Activities of Triazole-Containing Benzo[d]oxazoles
CNS & Neurological Disorders - Drug Targets Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia
Endocrine, Metabolic & Immune Disorders - Drug Targets Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer’s Disease
Current Alzheimer Research The Metabotropic Glutamate Receptors: Structure, Activation Mechanism and Pharmacology
Current Drug Targets - CNS & Neurological Disorders Ion Channels as Important Targets for Antiepileptic Drug Design
Current Drug Targets